Trans-Pacific Technology Fund (TPTF)
Our Mission: The Trans-Pacific Technology Fund (TPTF) is a technology-driven venture capital fund, investing in innovative companies shaping the future of global business. We work actively with the leadership of our portfolio companies from different regions of the world, supporting their growth. Our Approach: At TPTF, we believe the cornerstone of every great company is great people. Before a fascinating innovation can become a game-changing company on a global scale, we believe there needs to be daring entrepreneurs to convert the concept into reality. In addition to providing capital, we consider ourselves a committed partner, supporting our entrepreneurs via our extensive international resources, deep domain expertise and, most importantly, our passion to work together to build great companies. Our Focus Area: We invest in disruptive, platform technologies focusing on the sectors where we have leading domain expertise, including but not limited to: advanced materials, health/life sciences, ICT, IOT and robotics/automation. We have a multi-stage investment strategy to work with companies ranging from early to expansion/late stage. Through our extensive network of collaborative partners around the world, we have a global investment scope, seeking to invest in companies across Asia, North America and Europe.
Rey is a pioneering health and life insurance provider in Indonesia, established in 2021. It operates on a digital platform designed to offer comprehensive life, health, and critical illness insurance, distinguishing itself from traditional insurance models. Rey emphasizes a holistic approach to healthcare, integrating wellness and preventative care into its offerings while prioritizing the quality of services provided to its members. By leveraging technology, Rey aims to simplify the insurance experience, eliminating cumbersome paper processes and providing a personalized, data-driven approach. The company's mission is to transform the perception of insurance from a mere necessity into a desirable service that enhances the overall well-being of its users. Rey's diverse team is committed to reimagining the life and health insurance landscape in Indonesia, making it more accessible and aligned with the needs of its customers.
Rey is a pioneering health and life insurance provider in Indonesia, established in 2021. It operates on a digital platform designed to offer comprehensive life, health, and critical illness insurance, distinguishing itself from traditional insurance models. Rey emphasizes a holistic approach to healthcare, integrating wellness and preventative care into its offerings while prioritizing the quality of services provided to its members. By leveraging technology, Rey aims to simplify the insurance experience, eliminating cumbersome paper processes and providing a personalized, data-driven approach. The company's mission is to transform the perception of insurance from a mere necessity into a desirable service that enhances the overall well-being of its users. Rey's diverse team is committed to reimagining the life and health insurance landscape in Indonesia, making it more accessible and aligned with the needs of its customers.
Developer of an AI-powered health-tech software designed to humanize the way health is managed. The company's AI-based health management platform focuses on digital healthcare services and delivers telemedicine and other basic primary care services for healthcare payers which includes insurance companies, corporates, and government entities, enabling users to reduce claims and healthcare costs and make healthcare affordable.
Rey is a pioneering health and life insurance provider in Indonesia, established in 2021. It operates on a digital platform designed to offer comprehensive life, health, and critical illness insurance, distinguishing itself from traditional insurance models. Rey emphasizes a holistic approach to healthcare, integrating wellness and preventative care into its offerings while prioritizing the quality of services provided to its members. By leveraging technology, Rey aims to simplify the insurance experience, eliminating cumbersome paper processes and providing a personalized, data-driven approach. The company's mission is to transform the perception of insurance from a mere necessity into a desirable service that enhances the overall well-being of its users. Rey's diverse team is committed to reimagining the life and health insurance landscape in Indonesia, making it more accessible and aligned with the needs of its customers.
Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs.
The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models.
Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.
Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs.
The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models.
Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. The company integrates automation, machine learning, and genomics to enhance its platform, which aids in optimizing microbial strains and improving the efficiency of production processes. By leveraging big data and artificial intelligence, Zymergen collaborates with clients to engineer novel molecules from microbes, thereby advancing product development. Founded in 2013 and headquartered in Emeryville, California, Zymergen also has offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, enabling it to serve a global clientele effectively.
Heal, Inc. operates an on-demand healthcare platform that connects patients with licensed, background-checked pediatricians and family doctors for house calls and telemedicine services. Founded in 2014 and based in Los Angeles, the company offers its services across several states, including California, Georgia, Maryland, New Jersey, New York, Virginia, Washington, and the District of Columbia. Patients can schedule appointments through Heal's mobile application available on both the App Store and Google Play. The service is designed to provide timely and convenient medical care for various needs, including urgent care, primary care, and preventive care, with costs typically around $99 or covered by select insurance co-pays. Heal aims to enhance the patient experience by making quality healthcare more accessible while ensuring that doctors can practice medicine in a fulfilling way.
Kata.ai is an Indonesian company specializing in conversational artificial intelligence, aimed at enhancing the interaction between humans and machines. Utilizing advanced natural language processing technology, Kata.ai develops intelligent chatbots for various industries, including fast-moving consumer goods and telecommunications, serving notable clients such as Unilever and Telkomsel. The company's proprietary Kata Bot Platform allows businesses of all sizes to create customized chatbots for popular messaging channels, facilitating automated conversations and improving customer engagement. Established in 2015, Kata.ai has forged partnerships with major corporations like Microsoft and Accenture, and in 2017, it secured Series-A funding led by Trans-Pacific Technology Fund.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.